Beneficial effects of ropivacaine in rat experimental colitis

Journal of Pharmacology and Experimental Therapeutics

Volumn 291, Issue 2, 1999, Pages 642-647

  Martinsson, Titti ^a   Ljung, Tryggve ^b   Rubio, Carlos ^b   Hellstrom, Per M ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; MESALAZINE; ROPIVACAINE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON INJURY; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; ULCER HEALING; ULCERATIVE COLITIS;

ACETYLCHOLINE; AMIDES; ANESTHETICS, LOCAL; ANIMALS; BUDESONIDE; COLITIS; ETHANOL; GASTROINTESTINAL MOTILITY; MALE; MESALAMINE; MUCOUS MEMBRANE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRINITROBENZENESULFONIC ACID; WOUND HEALING;

EID: 0032722236     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alican I and Kubes P (1996) A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 270:G225-G237.
2. Arlander E, Öst Å, Ståhlberg D and Löfberg R (1996) Ropivacaine gel in active distal ulcerative colitis and proctitis: A pharmacokinetic and exploratory clinical study. Aliment Pharmacol Ther 10:73-81.
3. Babbs CF (1992) Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13:169-181.
4. Bennett A, Hensby CN, Sanger GJ and Stamford IF (1981) Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br J Pharmacol 74:435-444.
5. Bertrán X, Mañé J, Fernández-Bañares F, Castellá E, Bartolí R, Ojanguren I, Esteve M and Gassull MA (1996) Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut 38:899-904.
6. Biber B and Fara J (1973) Intestinal motility increased by tetrodotoxin, lidocaine and procaine. Experientia 29:551-552.
7. Björck S, Dahlström A and Ahlman H (1993) Treatment of distal ulcerative colitis with lidocaine. Can J Gastroenterol 7:179-181.
8. Bortoff A and Muller R (1975) Stimulation of intestinal smooth muscle by atropine, procaine, and tetrodotoxin. Am J Physiol 226:1609-1613.
9. Cederholm I, Briheim G, Rutberg H and Dahlgren C (1994) Effects of five aminoamide local anaesthetic agents on human polymorphonuclear leukocytes measured by chemiluminescence. Acta Anaesthesiol Scand 38:704-710.
10. Cullen BF and Haschke RH (1974) Local anesthetic inhibition of phagocytosis and metabolism of human leukocytes. Anesthesiology 40:142-146.
11. Ekström GM (1998) Oxazolone-induced colitis in rats: Effects of budesonide, cyclosporin A, and 5-aminosalicylic acid. Scand J Gastroenterol 33:174-179.
12. 4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation. Agents Actions 27:395-397.
13. Laszlo F, Whittle BJ and Moncada S (1994) Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 111:1309-1315.
14. Lundberg JO, Hellstrom PM, Lundberg JM and Alving K (1994) Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344:1673-1674.
15. MacGregor RR, Thorner RE and Wright DM (1980) Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 56:203-209.
16. Martinsson T (1999) Ropivacaine inhibits serum-induced proliferation of colon adenocarcinoma cells in vitro. J Pharmacol Exp Ther 288:660-664.
17. Martinsson T, Haegerstrand A and Dalsgaard C-J (1997a) Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro. Inflamm Res 46:398-403.
18. Martinsson T, Oda T, Fernvik E, Roempke K, Dalsgaard C-J and Svensjö E (1997b) Ropivacaine inhibits leukocyte rolling, adhesion and CD11b/CD18 expression. J Pharmacol Exp Ther 283:59-65.
19. McCafferty D-M, Sharkey KA and Wallace JL (1994) Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol 266:G560-G567.
20. McCafferty D-M, Wallace JL and Sharkey KA (1997) Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol 272:G272-G280.
21. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR and Wallace JL (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803.
22. Morteau O, More J, Pons L and Bueno L (1993) Platelet-activating factor and interleukin 1 are involved in colonic dyamotility in experimental colitis in rats. Gastroenterology 104:47-56.
23. Mourelle M, Casellas F, Guarner F, Salas A, Riveros-Moreno V, Moncada S and Malagelada JR (1995) Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 109:1497-1502.
24. Nielsen-Kudsk JE (1996) Potassium channel modulation: A new drug principle for regulation of smooth muscle contractility: Studies on isolated airways and arteries. Dan Med Bull 43:429-447.
25. Palmen MJHJ, Dijkstra CD, van der Ende MB, Peña AS and van Rees EP (1995) Anti-CD11b/CD18 antibodies reduce inflammation in acute colitis in rats. Clin Exp Immunol 101:351-356.
26. Roediger WEW, Lawson MJ, Nance SH and Radcliffe BC (1986) Detectable colonic nitrite levels in inflammatory bowel disease: Mucosal or bacterial malfunction? Digestion 35:199-204.
27. Sanger GJ and Bennett A (1980) Regional differences in the responses to prostanoids of circular muscle from guinea-pig isolated intestine. J Pharm Pharmacol 32:705-708.
28. Schierwagen C, Bylund-Felenius A-C and Lundberg C (1990) Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23:179-186.
29. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86:453-460.
30. 4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 37:159-165.
31. Snape WJ Jr, Matarazzo SA and Cohen S (1980) Abnormal gastrocolonic response in patients with ulcerative colitis. Gut 21:392-396.
32. Snape WJ Jr and Tan S-T (1985) Role of sodium or calcium in electrical depolarization of feline colonic smooth muscle. Am Physiol 249:G66-G72.
33. Snape WJ Jr, Williams R, Mayer EA and Root D (1987) Disturbance in colonic contraction in colonic muscle removed from patients with ulcerative colitis (Abstract). Gastroenterology 92:1648.
34. Spriggs EA, Code CF, Bargen JA, Curtiss RK and Hightower NC Jr (1951) Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology 19:480-491.
35. Wallace JL, Byles NIA and Scott RB (1991) Inflammatory mediators and gastrointestinal motility, in Effects of Immune Cells and Inflammation on Smooth Muscle and Enteric Nerves (Snape WJ Jr and Collins SM eds) pp 271-280, CRC Press, Boca Raton, FL.
36. Wallace JL, MacNaughton WK, Morris GP, Beck PL (1989) Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29-36.
37. Wood JD (1972) Excitation of intestinal muscle by atropine, tetrodotoxin, and xylocaine. Am J Physiol 222:118-125.